The recognition that
bacterial infections induce signal transduction responses in infected epithelial cells also provides new avenues to consider as novel forms of
therapy. For example, the
chemokine interleukin-8, which attracts neutrophils to sites of mucosal
infection, is produced by epithelial cells of gastric and intestinal origin in response to
bacterial infection. Inhibitors of
chemokine production or inhibition of the
biologic effects of neutrophil
chemoattractants have the potential to reduce both mucosal inflammatory responses and the attendant clinical sequelae. Eukaryotic cells also respond to
infection with elevations in cytosolic second messengers, including
inositol triphosphate (IP3) and
calcium ([Ca2+]i). In intestinal epithelium, these second messengers can mediate the diarrheal response to
infection.
Calcium/
calmodulin inhibitors may have a beneficial effect in treating those gastrointestinal
infections mediated through changes in the level of cytosolic free
calcium. DuPont and colleagues showed, for example, that oral
therapy with
zaldaride maleate relieves symptoms of disease and shortens the duration of
diarrhea in travelers with ETEC-induced
diarrhea. Evaluation of additional signal transduction responses to microbial
infections should provide both new insights into the pathogenesis of gastrointestinal
infectious diseases and novel approaches to consider for the prevention and
therapy for these human illnesses.